Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
European Journal of Clinical Pharmacology|January 1, 1991
Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patientsT W Gehr, D A Sica, D M Grasela, et al.Circulation Research|November 1, 1983
Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertensionI Ichikawa, R A Ferrone, K L Duchin, et al.Journal of Clinical Pharmacology|January 1, 1991
Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjectsK L Duchin, A P Waclawski, J I Tu, et al.Clinical Pharmacology and Therapeutics|April 1, 1991
Pharmacokinetics of fosinopril in patients with various degrees of renal functionK K Hui, K L Duchin, K J Kripalani, et al.British Journal of Clinical Pharmacology|January 1, 1988
Disposition of fosinopril sodium in healthy subjectsS M Singhvi, K L Duchin, R A Morrison, et al.Journal of Clinical Pharmacology|February 1, 1983
Acute electrophysiologic effects of nadololI S Cohen, W Widrich, K L Duchin, et al.Journal of Clinical Pharmacology|March 1, 1997
Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virusX J Zhou, K Squires, X R Pan-Zhou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Phase I trial of orally administered pentosan polysulfate in patients with advanced cancerJ L Marshall, A Wellstein, J Rae, et al.Hypertension (Dallas, Tex. : 1979)|May 1, 1991
Once-daily fosinopril in the treatment of hypertensionR J Anderson, K L Duchin, R D Gore, et al.Pageof 3